Roderick H. MacLeod's most recent trade in Nevro Corp was a trade of 1,136 Common Stock done . Disclosure was reported to the exchange on March 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 1,136 | 113,998 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.78 per share. | 20 Mar 2025 | 611 | 113,387 (0%) | 0% | 5.8 | 3,532 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 07 Mar 2025 | 15,136 | 112,862 (0%) | 0% | 5.8 | 87,335 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.77 per share. | 07 Mar 2025 | 1,763 | 127,998 (0%) | 0% | 5.8 | 10,173 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 1,143 | 129,761 (0%) | 0% | 5.7 | 6,538 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 805 | 130,904 (0%) | 0% | 5.7 | 4,605 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 742 | 132,101 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 392 | 131,709 (0%) | 0% | 5.7 | 2,242 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share. | 07 Dec 2024 | 1,759 | 131,359 (0%) | 0% | 4.2 | 7,370 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.58 per share. | 28 Nov 2024 | 816 | 133,118 (0%) | 0% | 4.6 | 3,737 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.18 per share. | 07 Sep 2024 | 1,759 | 133,934 (0%) | 0% | 5.2 | 9,112 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.76 per share. | 28 Aug 2024 | 817 | 135,693 (0%) | 0% | 5.8 | 4,706 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 15 Jun 2024 | 1,619 | 136,510 (0%) | 0% | 9.0 | 14,620 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.27 per share. | 07 Jun 2024 | 1,759 | 138,129 (0%) | 0% | 9.3 | 16,306 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.52 per share. | 28 May 2024 | 816 | 139,888 (0%) | 0% | 9.5 | 7,768 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 84,326 | 147,840 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.32 per share. | 07 Mar 2024 | 7,136 | 140,704 (0%) | 0% | 15.3 | 109,324 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 743 | 63,952 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 04 Mar 2024 | 438 | 63,514 (0%) | 0% | 14.5 | 6,355 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.22 per share. | 02 Mar 2024 | 1,270 | 63,209 (0%) | 0% | 14.2 | 18,059 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.82 per share. | 28 Feb 2024 | 898 | 64,479 (0%) | 0% | 14.8 | 13,308 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.67 per share. | 28 Nov 2023 | 800 | 65,377 (0%) | 0% | 16.7 | 13,336 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.39 per share. | 28 Aug 2023 | 800 | 66,177 (0%) | 0% | 19.4 | 15,512 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.97 per share. | 15 Jun 2023 | 1,585 | 66,977 (0%) | 0% | 25.0 | 39,577 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.45 per share. | 28 May 2023 | 800 | 68,562 (0%) | 0% | 26.5 | 21,160 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 39,282 | 69,362 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.99 per share. | 02 Mar 2023 | 1,133 | 30,080 (0%) | 0% | 34.0 | 38,511 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.44 per share. | 28 Feb 2023 | 3,352 | 31,213 (0%) | 0% | 31.4 | 105,387 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.25 per share. | 15 Jun 2022 | 1,579 | 34,565 (0%) | 0% | 42.3 | 66,713 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.27 per share. | 02 Mar 2022 | 1,186 | 36,144 (0%) | 0% | 71.3 | 84,526 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 18,249 | 37,330 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.49 per share. | 15 Jun 2021 | 1,583 | 19,081 (0%) | 0% | 158.5 | 250,890 | Common Stock |
| Nevro Corp | Roderick H. MacLeod | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 8,612 | 20,664 (0%) | 0% | 0 | Common Stock |